Severe Isotype-Matched Immunosuppression (IMI) as a Potential Risk Factor for Progression of MGUS Patients
Juana J Jiménez1, Tiago M Pais2, Nuno Barbosa2
1Department of Clinical Chemistry, University Hospital Severo Ochoa, Madrid, Spain.
Background:
Monoclonal gammopathy of undetermined significance (MGUS) precedes multiple myeloma in virtually every case. However, only a small percentage will progress and at very different rates. In addition, recent data have suggested that MGUS is associated with other comorbidities including infections, suggesting impaired immune function in some MGUS patients. Therefore, we aimed at assessing the value of isotype-matched immunosuppression (IMI; e.g., suppression of an IgAκ in an IgAλ patient), a type of immunosuppression more specific than classical immunoparesis (IP; e.g., IgG and/or IgM suppression in an IgA patient), as a prognostic marker for MGUS progression.
Methods:
The Hevylite assay was used to assess IMI and immunoglobulin ratios in 307 serum samples from a cohort of 248 MGUS patients. Follow-up clinical records were available for 154 individuals.
Results:
A greater incidence of IMI (51%) over classical IP (37%) was observed, although both show a progressive increase with higher risk groups. Survival analysis of 154 patients showed that severe IMI (>50% suppression) differentiates 2 groups with significantly different time to progression (P = 0.024) while severe IP does not (P = 0.48). Also, a combination of severe IMI and involved monoclonal immunoglobulin >1.5g/dL by Hevylite (both variables found to be independent prognostic markers in multivariate analysis) identified a group of patients with a median time to progression 6-fold shorter than the remaining group (P < 0.0001).
Conclusions:
These findings indicate a possible role for IMI in the malignant transformation of MGUS patients and a potential utility as a new risk factor.
Insights
Isotype-matched immunosuppression (IMI) is a potential prognostic marker for monoclonal gammopathy of undetermined significance (MGUS) progression. Severe IMI, especially with high monoclonal immunoglobulin levels, identifies patients with a significantly shorter time to progression.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Monoclonal gammopathy of undetermined significance (MGUS) precedes multiple myeloma but progression rates vary.
- MGUS is linked to comorbidities like infections, suggesting immune dysfunction in some patients.
- Isotype-matched immunosuppression (IMI) is a more specific measure of immune suppression than classical immunoparesis (IP).
Purpose of the Study:
- To evaluate isotype-matched immunosuppression (IMI) as a prognostic marker for MGUS progression.
- To compare the prognostic value of IMI versus classical immunoparesis (IP).
Main Methods:
- The Hevylite assay was used to measure IMI and immunoglobulin ratios in 307 MGUS serum samples.
- Clinical follow-up data from 154 MGUS patients were analyzed.
- Survival analysis was performed to assess time to progression.
Main Results:
- IMI occurred more frequently (51%) than IP (37%) and both increased with higher risk groups.
- Severe IMI (>50% suppression) significantly differentiated time to progression (P = 0.024), unlike severe IP (P = 0.48).
- A combination of severe IMI and high monoclonal immunoglobulin (>1.5g/dL) identified a high-risk group with a 6-fold shorter median time to progression (P < 0.0001).
Conclusions:
- Isotype-matched immunosuppression (IMI) may play a role in the malignant transformation of MGUS.
- IMI shows potential as a novel risk factor for predicting MGUS progression.
- These findings could aid in identifying MGUS patients who require closer monitoring or earlier intervention.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:14Myocarditis III: Medical Management